Top Markets
#1 Nesa Nesa +797.03%
#2 Cortex Cortex +68.91%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.76%
#4 QuantixAI QuantixAI +40.81%
#5 Pons Pons +25.08%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +20.00%
#8 Renzo Restaked LST Renzo Restaked LST +10.38%
#9 Fartcoin Fartcoin +9.77%
#10 PondCoin PondCoin +8.97%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
OnKure Therapeutics, Inc. OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKUR
Rank in Stocks #19593
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a... OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
Share Price
$3.86
Last synced: 2026-08-25
Market Cap
$156.32M
Change (1 day)
-0.77%
Change (1 year)
40.36%
Country
US
Trade OnKure Therapeutics, Inc. (OKUR)

Category

Healthcare
Number of shares outstanding for OnKure Therapeutics, Inc. (OKUR)
Number of shares outstanding as of August 2026: 0
According to OnKure Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for OnKure Therapeutics, Inc. (OKUR) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH